Welcome to LookChem.com Sign In | Join Free   Post buying lead  Chemical Tools
Post Buying Lead

Detail of > 150812-12-7

  • CAS Number:
  • 150812-12-7
  • Name:
  • Retigabine

  • Formula:
  • C16H18FN3O2
  • Molecular Structure:
  • Synonyms:
  • Carbamicacid, [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester (9CI);Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate;
  • Molecular Weight:
  • 303.33
  • Density:
  • 1.307 g/cm3
  • Boiling Point:
  • 430 ºC at 760 mmHg
  • Flash Point:
  • 213.9 ºC
Home > Products > 150812-12-7

Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!

Supplier Location:
China (Mainland)(19)Japan(1)
Business Type:
Importer/Exporter(13)Lab/Research institutions(5)Other(1)
Certificates:
ISO(1) Production License (0)

Page:1/1   

CAS No. 

150812-12-7 Retigabine Competitive Product

Retigabine
China (Mainland)   3742
  • Tel:+86-21-58116475
  • Address:Zhoukang Road,Pudong New District,Shanghai,China

CAS No. 

150812-12-7 RetigabineCompetitive Product

Assay:99%
China (Mainland)   1754
  • Tel:+86-411 82593920, 82593631
  • Address:No 232, JInma Roda, Development Zone, Dalian, China

CAS No. 

150812-12-7 RetigabineCompetitive Product

China (Mainland)   1412
  • Tel:86-576-88813233 88205808
  • Address:Economic Developed Zone of Taizhou Zhejiang China
MSN:crene-pharm@hotmail.com Yahoo! Messenger

CAS No. 

150812-12-7 RetigabineCompetitive Product

China (Mainland)   1882
  • Tel:86-10-59071915
  • Address:4A/F, Building A, Vantone Center, No.6 Jia, Chaoyangmenwai Avenue, Chaoyang District
MSN:saleengao@hotmail.com

CAS No. 

150812-12-7 Retigabine

Assay:98%  Appearance:purple
MF: C16H18FN3O2 Grade Standard: enterprise standard
China (Mainland)   1774
  • Tel:041162933057
MSN:zihaolee@msn.cn

CAS No. 

150812-12-7 Retigabine

Assay:≥99%(HPLC)  Appearance:Inqury  Package:1G,5G,90G
China (Mainland)   1038
  • Tel:+86-021-50182336
  • Address:Room 1305,Building 1,No.Jinyu Road,Pudong New District
MSN:demochem007@hotmail.com

CAS No. 

150812-12-7 Retigabine

2-Amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzene
China (Mainland)   1094
  • Tel:86-21-50135380
  • Address:No.868 Sanlin Road,Room 207 Pudong New Area,Shanghai 201201,China

CAS No. 

150812-12-7 Retigabine

Retigabine
China (Mainland)   1540
  • Tel:+86-021-51601763
  • Address:1.Room 04,20/F,Shiye Mansion,No. 18 Caoxi north street,Xuhui district,Shanghai,China

CAS No. 

150812-12-7 Retigabine

RETIGABINE
China (Mainland)   2295
  • Tel:0086-531-58773055
  • Address:NO.59 Gongye South Road

CAS No. 

150812-12-7 Retigabine

China (Mainland)   3010
  • Tel:+86-571-88323393
  • Address:No.16, Xuelin street
MSN:worldwidely@hotmail.com

CAS No. 

150812-12-7 Retigabine

China (Mainland)   ISO  4490
  • Tel:+86-571-88938639
  • Address:B/2601 Fuli Building, 328# WenEr Rd. Hangzhou City 310012 China

CAS No. 

150812-12-7 Retigabine

China (Mainland)   3012
  • Tel:86-24-86136788
  • Address:No.134 Changjiang Street,Huanggu District,Shenyang,Liaoning,China.
MSN:monica16280@live.cn

CAS No. 

150812-12-7 Retigabine

China (Mainland)   1692
  • Tel:+86-311-86963880
  • Address:Room 818 ,Lomo north Building ,PingAn street,zhongshan Road,Qiaodong District, Shijiazhuang City ,Hebei Province,China
MSN:neil-du@hotmail.com

CAS No. 

150812-12-7 Retigabine

Assay:≥99.0%
China (Mainland)   1794
  • Tel:0086-576-88525005, 88880039
  • Address:B Area. 10 Floor.Yaodadasha. 289#.Shifu Road.Taizhou.Zhejiang.China

CAS No. 

150812-12-7 Retigabine

RETIGABINE Assay: ≥99.5% Single most impurity:≤0.5%
China (Mainland)   2008
  • Tel:86+18606177916
  • Address:Liberation Road S.High-tech innovation centre

CAS No. 

150812-12-7 Retigabine

Retigabine
China (Mainland)   998
  • Tel:+86-571-85617789
  • Address:Rm 409 Wenxin Building No.207, Wen'er Road, Hangzhou, China

CAS No. 

150812-12-7 Retigabine

Product name Retigabine CAS No. 150812-12-7 Molecular Formula C16H18FN3O2 Molecular Weight 303.33 Spec. Assay 99% Usage: A new experimental anticonvulsant drug. Anxiolytic.
China (Mainland)   60
  • Tel:86-27-85767163
  • Address:314# Xinhua Road, Wuhan, China

CAS No. 

150812-12-7 Retigabine

China (Mainland)   2074
  • Tel:+86-576-88850501
  • Address:Jiaojiang District, Taizhou City, Zhejiang Province, China

CAS No. 

150812-12-7 Retigabine

Japan  
  • Tel:+81 3 35364670
  • Address:2-15-13 Tsukishima, Chuo-ku Tokyo, 1040052, Japan

CAS No. 

150812-12-7 Retigabine

China (Mainland)   4
  • Tel:86-21-61556465
  • Address:Room 1919,building 3,No.277 Zheqiao Road,Pudong New District,Shanghai
  • Total:20 Page 1 of 1 1
  • Please post your buying leads,so that our qualified suppliers will soon contact you!
    *Required Fields

    Reference

    Antidystonic effects of Kv7 (KCNQ) channel openers in the dtsz mutant, an animal model of primary paroxysmal dystonia
    All Rights Reserved. Antidystonic effects of Kv7 (KCNQ) channel openers in the dtsz mutant, an animal model of primary paroxysmal dystonia. Richter, A.; Sander, S. E.; Rundfeldt, C. (Institute of Pharmacology and Toxicology, Department of Veterinary Medicine, Freie Universitaet Berlin, Berlin 14195, Germany). British Journal of Pharmacology, 149(6), 747-753 (English) 2006 Nature Publishing Group. CODEN: BJPCBM. ISSN: 0007-1188. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) Mutations in neuronal Kv7 (KCNQ) potassium channels can cause episodic neurol. disorders. The role of Kv7 channels in the pathogenesis and as targets for the treatment of paroxysmal dyskinesias with dystonia have so far not been examd. In the present study, the authors therefore examd. the effects of the activators of neuronal Kv7.2/7.There are some reagents with their cas registry numbers 56995-20-1 and 150812-12-7 are used in this study.3 channels retigabine (5, 7.5, 10 mg kg-1 i.p. and 10, 20 mg kg-1 p.o.) and flupirtine (10, 20 mg kg-1 i.p.) and of the channel blocker 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone (XE-991, 3 and 6 mg kg-1 i.p.) in the dtsz mutant hamster, a model of paroxysmal dyskinesia in which dystonic episodes occur in response to stress. Retigabine (10 mg kg-1 i.p., 20 mg kg-1 p.o.) and flupirtine (20 mg kg-1 i.p.) significantly improved dystonia, while XE-991 caused a significant aggravation in the dtsz mutant. The antidystonic effect of retigabine (10 mg kg-1 i.p.) was counteracted by XE-991 (3 mg kg-1 i.p.). These data indicate that dysfunctions of neuronal Kv7 channels deserve attention in dyskinesias. Since retigabine and flupirtine are well tolerated in humans, the present finding of pronounced antidystonic efficacy in the dtsz mutant suggests that neuronal Kv7 channel activators are interesting candidates for the treatment of dystonia-assocd. dyskinesias and probably of other types of dystonias. The established analgesic effects of Kv7 channel openers might contribute to improvement of these disorders which are often accompanied by painful muscle spasms. .

    ©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

    [Hangzhou]86-571-85317600,85317603,85317620